Compare NBY & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NBY | CBRE |
|---|---|---|
| Founded | 2000 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.2M | 48.3B |
| IPO Year | 2007 | 2004 |
| Metric | NBY | CBRE |
|---|---|---|
| Price | $5.35 | $160.83 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $177.25 |
| AVG Volume (30 Days) | ★ 2.2M | 1.6M |
| Earning Date | 11-07-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.63 |
| EPS | 0.47 | ★ 4.05 |
| Revenue | $10,302,000.00 | ★ $39,325,000,000.00 |
| Revenue This Year | $23.91 | $16.40 |
| Revenue Next Year | $32.05 | $9.30 |
| P/E Ratio | $205.94 | ★ $39.87 |
| Revenue Growth | ★ 390.34 | 14.61 |
| 52 Week Low | $0.46 | $108.45 |
| 52 Week High | $6.47 | $171.00 |
| Indicator | NBY | CBRE |
|---|---|---|
| Relative Strength Index (RSI) | 84.30 | 57.40 |
| Support Level | $2.92 | $158.20 |
| Resistance Level | $1.11 | $162.71 |
| Average True Range (ATR) | 0.71 | 3.41 |
| MACD | 0.30 | 0.12 |
| Stochastic Oscillator | 77.05 | 78.13 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.